Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

A 75-year-old woman with situs inversus totalis, dextrocardia, a patent foramen ovale (PFO), and a double-chamber right ventricle with subpulmonic outflow obstruction presented with highly symptomatic ...

The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...

A total of 38 AF ablation patients and 38 SVT ablation patients were included in the analysis (all with first follow-up). While the AF subjects were older and more often male, none of the other ...

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...